Hippocratic AI, a healthcare-focused artificial intelligence startup, has raised $141 million in a Series B funding round led by Kleiner Perkins, with participation from A16z, NVIDIA, General Catalyst, and others, bringing its valuation to $1.64 billion. This funding will accelerate the development of its generative AI agents designed to address global healthcare staffing shortages, including nurses, social workers, and nutritionists. The company’s AI agents, trained and validated with input from licensed clinicians, handle tasks like chronic care management, medication checks, and patient education. Clinicians can create specialized AI agents using the newly launched Healthcare AI Agent App Store, allowing them to incorporate their expertise into solutions tailored to specific healthcare needs. The platform also enables clinicians to earn revenue based on their agents’ performance.
Hippocratic AI ensures the safety and efficacy of its agents through a rigorous multi-step evaluation process involving over 6,000 nurses and 300 doctors. Its agents address a variety of tasks, including maternal mental health assessments, diabetes screening, pre- and post-surgery wound care, and more. With early adoption by organizations like OhioHealth, Cincinnati Children’s, and WellSpan Health, the startup has made significant strides since its last funding round, achieving patents, verifying agent safety, and securing contracts with 23 healthcare clients. CEO Munjal Shah emphasized the company’s mission to create “healthcare abundance” through AI-driven staffing innovations, leveraging no-code development and AI agents to ease the burden on overworked clinicians.
Read the full article here